{"References": [{"title": "Lipoxins and aspirin-triggered lipoxins in resolution of inflammation", "authors": "Charles N. Serhan, Nan Chiang, Thomas E. Van Dyke", "journal": "The Scientific World Journal", "year": "2003", "volumes": "3", "first page": "140", "last page": "161", "DOI": "10.1100/tsw.2003.63"}, {"title": "Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-κB and AP-1 activation, and IL-8 gene expression in human leukocytes", "authors": "Jesmond Dalli, Romain A. Colas, Charles N. Serhan", "journal": "Scientific Reports", "year": "2013", "volumes": "3", "first page": "1", "last page": "13", "DOI": "10.1038/srep01675"}, {"title": "Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism", "authors": "Bruce D. Levy, Gabrielle J. Lukacs, Aaron A. Berlin, Birgitta Schmidt, William J. Guilford, Charles N. Serhan, John F. Parkinson", "journal": "The FASEB Journal", "year": "2007", "volumes": "21", "first page": "3877", "last page": "3884", "DOI": "10.1096/fj.07-8653com"}, {"title": "Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis", "authors": "Yan Wu, Yong-Sheng Zhai, Xiao-Ying Li, Jian-Xin Zhu", "journal": "Scientific Reports", "year": "2017", "volumes": "7", "first page": "1", "last page": "11", "DOI": "10.1038/s41598-017-08522-9"}, {"title": "Lipoxin A4 and its analogs in cancer and inflammation: Pro-resolution or dangerous liaisons?", "authors": "Olivier Perretti, Mauro Perretti, Charles D. Flower", "journal": "The FASEB Journal", "year": "2020", "volumes": "34", "first page": "7658", "last page": "7673", "DOI": "10.1096/fj.202000053R"}, {"title": "Lipoxin A4 and 15-epi-lipoxin A4 protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain", "authors": "Shanshan Wu, Romain A. Colas, Patricia C. Nouyen, Jesmond Dalli, Eun-Hee Choi, Allison R. Gartung, Charles N. Serhan, Dipak K. Panigrahy", "journal": "Proceedings of the National Academy of Sciences", "year": "2020", "volumes": "117", "first page": "32614", "last page": "32622", "DOI": "10.1073/pnas.2007987117"}, {"title": "Lipoxin A4 and its analog resolve inflammation in a murine model of sickle cell disease", "authors": "Mélanie Souffriau, Jesmond Dalli, Charles N. Serhan, Koen Poppe, Katrien Breckpot, Jo A. Van Ginderachter, Alain Beschin", "journal": "Haematologica", "year": "2019", "volumes": "104", "first page": "1382", "last page": "1393", "DOI": "10.3324/haematol.2018.208678"}, {"title": "Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment", "authors": "Weicang Wang, Huanhuan Ye, Peng Wei, Bin Han, Weihua He, Jinghua Tian, Xiaomei Yang, Yongsheng Zhai, Jianxin Zhu, Yan Wu", "journal": "Cancer Letters", "year": "2018", "volumes": "422", "first page": "56", "last page": "69", "DOI": "10.1016/j.canlet.2018.02.019"}, {"title": "Lipoxin A4 and its analog resolve inflammation in a murine model of Alzheimer's disease", "authors": "Yan Wu, Yong-Sheng Zhai, Xiao-Ying Li, Jian-Xin Zhu", "journal": "Neuropharmacology", "year": "2020", "volumes": "166", "first page": "107952", "last page": "", "DOI": "10.1016/j.neuropharm.2020.107952"}, {"title": "Lipoxin A4 and its analog attenuate the inflammatory response in cystic fibrosis airway cells", "authors": "Valérie Urbach, Valia Verriere, Yassine Grumbach, Joseph Bousquet, Brian J. Harvey, Nathalie Vergnolle, Mauro Perretti", "journal": "Journal of Cystic Fibrosis", "year": "2012", "volumes": "11", "first page": "455", "last page": "461", "DOI": "10.1016/j.jcf.2012.04.003"}]}